News

The drug, which is similar to compounds used to treat diabetes, could be one of the first treatments to directly target the progression of the...

The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology Laboratory (PCL),...

Cadila Healthcare has announced that it has gained FDA final approval to market Nifedipine ER tablets and cholestyramine oral suspension.

Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine auto injector Symjepi in the...

Despite threats from President Trump, Pfizer has just hefted the price of 40 of its drugs in its second round of hikessince the beginning of the...

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and speed up the...

The Brussels-based pharmaceutical company UCB has announced that the European Medicines Agency (EMA) has approved a label extension for Cimzia (...

Roche has unveiled new Phase 3 data on Tecentriq in combination with chemotherapy as a first-line treatment, confirming that it met its co-primary...

It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have received approval in...

Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio, has been approved for the treatment of patients with moderately to...